Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 30, 2019 | Apr. 26, 2019 | |
Document And Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 30, 2019 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q1 | |
Trading Symbol | AMD | |
Entity Registrant Name | ADVANCED MICRO DEVICES INC | |
Entity Central Index Key | 0000002488 | |
Current Fiscal Year End Date | --12-28 | |
Entity Filer Category | Large Accelerated Filer | |
Entity Emerging Growth Company | false | |
Entity Small Business | false | |
Entity Common Stock, Shares Outstanding | 1,081,600,723 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
Mar. 30, 2019 | Mar. 31, 2018 | |
Income Statement [Abstract] | ||
Net revenue | $ 1,272 | $ 1,647 |
Cost of sales | 751 | 1,050 |
Gross margin | 521 | 597 |
Research and development | 373 | 343 |
Marketing, general and administrative | 170 | 134 |
Licensing gain | (60) | 0 |
Operating income | 38 | 120 |
Interest expense | (27) | (31) |
Other income (expense), net | (7) | 1 |
Income before income taxes and equity loss | 4 | 90 |
Provision (benefit) for income taxes | (13) | 8 |
Equity loss in investee | (1) | (1) |
Net income | $ 16 | $ 81 |
Earnings per share | ||
Basic (in usd per share) | $ 0.01 | $ 0.08 |
Diluted (in usd per share) | $ 0.01 | $ 0.08 |
Shares used in per share calculation | ||
Basic (in shares) | 1,044 | 968 |
Diluted (in shares) | 1,094 | 1,039 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Millions | 3 Months Ended | |
Mar. 30, 2019 | Mar. 31, 2018 | |
Statement of Comprehensive Income [Abstract] | ||
Net income (loss) | $ 16 | $ 81 |
Unrealized gains (losses) on cash flow hedges: | ||
Unrealized gains arising during the period | 5 | |
Reclassification adjustment for (gains) losses realized and included in net income | 2 | |
Total change in unrealized gains (losses) on cash flow hedges | 7 | |
Unrealized gains arising during the period | 1 | |
Reclassification adjustment for (gains) losses realized and included in net income | (4) | |
Total change in unrealized gains (losses) on cash flow hedges | (3) | |
Cumulative-effect adjustment to accumulated deficit related to the adoption of ASU 2016-01, Financial Instruments | 0 | 2 |
Total comprehensive income | $ 23 | $ 80 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Millions | Mar. 30, 2019 | Dec. 29, 2018 |
Current assets: | ||
Cash and cash equivalents | $ 978 | $ 1,078 |
Marketable securities | 216 | 78 |
Accounts receivable, net | 1,241 | 1,235 |
Inventories, net | 955 | 845 |
Prepayment and receivables—related parties | 50 | 52 |
Prepaid expenses | 65 | 57 |
Other current assets | 172 | 195 |
Total current assets | 3,677 | 3,540 |
Property and equipment, net | 377 | 348 |
Operating lease right-of-use assets | 214 | 0 |
Goodwill | 289 | 289 |
Investment: equity method | 57 | 58 |
Other assets | 317 | 321 |
Total assets | 4,931 | 4,556 |
Current liabilities: | ||
Short-term debt, net | 70 | 136 |
Accounts payable | 484 | 528 |
Payables to related parties | 446 | 533 |
Accrued liabilities | 719 | 763 |
Other current liabilities | 45 | 24 |
Total current liabilities | 1,764 | 1,984 |
Long-term debt, net | 1,024 | 1,114 |
Long-term operating lease liabilities | 213 | 0 |
Other long-term liabilities | 142 | 192 |
Contingencies (See Note 12) | ||
Capital stock: | ||
Common stock, par value $0.01; shares authorized: 2,250; shares issued: 1,087 and 1,010; shares outstanding: 1,082 and 1,005 | 11 | 10 |
Additional paid-in capital | 9,246 | 8,750 |
Treasury stock, at cost (shares issued: 5 and 5) | (48) | (50) |
Accumulated deficit | (7,420) | (7,436) |
Accumulated other comprehensive loss | (1) | (8) |
Total stockholders’ equity | 1,788 | 1,266 |
Total liabilities and stockholders’ equity | $ 4,931 | $ 4,556 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Mar. 30, 2019 | Dec. 29, 2018 |
Statement of Financial Position [Abstract] | ||
Common stock, par value (in usd per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 2,250,000,000 | 2,250,000,000 |
Common stock, shares issued (in shares) | 1,087,000,000 | 1,010,000,000 |
Common stock, shares outstanding (in shares) | 1,082,000,000 | 1,005,000,000 |
Treasury stock, shares (in shares) | 5,000,000 | 5,000,000 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions | 3 Months Ended | |
Mar. 30, 2019 | Mar. 31, 2018 | |
Cash flows from operating activities: | ||
Net income | $ 16 | $ 81 |
Adjustments to reconcile net income to net cash used in operating activities: | ||
Depreciation and amortization | 46 | 44 |
Stock-based compensation | 41 | 32 |
Amortization of debt discount and issuance costs | 9 | 10 |
Loss on debt redemption | 8 | 1 |
Loss on sale/disposal of property and equipment | 6 | 0 |
Other | (1) | 1 |
Changes in operating assets and liabilities: | ||
Accounts receivable | (5) | (295) |
Inventories | (110) | (21) |
Prepayment and receivables - related parties | 2 | 15 |
Prepaid expenses and other assets | (11) | 24 |
Payables to related parties | (87) | (38) |
Accounts payable, accrued liabilities and other | (127) | 39 |
Net cash used in operating activities | (213) | (107) |
Cash flows from investing activities: | ||
Purchases of property and equipment | (62) | (46) |
Purchases of available-for-sale debt securities | (231) | 0 |
Proceeds from maturity of available-for-sale debt securities | 93 | 0 |
Collection of deferred proceeds on sale of receivables | 25 | 21 |
Other | 2 | 0 |
Net cash used in investing activities | (173) | (25) |
Cash flows from financing activities: | ||
Proceeds from warrant exercise by related party | 449 | 0 |
Proceeds from issuance of common stock through employee equity incentive plans | 1 | 6 |
Repayments of long-term debt | (164) | (14) |
Net cash provided by (used in) financing activities | 286 | (8) |
Net decrease in cash, cash equivalents, and restricted cash | (100) | (140) |
Cash, cash equivalents, and restricted cash at beginning of period | 1,083 | 1,191 |
Cash, cash equivalents, and restricted cash at end of period | 983 | 1,051 |
Non-cash activities: | ||
Purchases of property and equipment, accrued but not paid | 62 | 47 |
Issuance of treasury stock to partially settle debt | 7 | 0 |
Deferred proceeds on sale of receivables | 0 | 11 |
Other | 3 | 0 |
Reconciliation of cash, cash equivalents, and restricted cash | ||
Cash and cash equivalents | 978 | 1,045 |
Restricted cash included in Other current assets | 5 | 3 |
Restricted cash included in Other assets | 0 | 3 |
Total cash, cash equivalents, and restricted cash | $ 1,083 | $ 1,191 |
Consolidated Statements of Stoc
Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions | Total | Common Stock | Additional paid-in capital | Treasury stock | Accumulated deficit | Accumulated other comprehensive income (loss) |
Beginning balance at Dec. 30, 2017 | $ 9 | $ 8,464 | $ (108) | $ (7,775) | $ 6 | |
Changes in Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||||||
Common stock issued under employee equity incentive plans, net of tax withholding | 1 | 6 | ||||
Issuance of common stock upon warrant exercise | 0 | 0 | ||||
Stock-based compensation | 32 | |||||
Issuance of treasury stock to partially settle debt | 0 | 0 | ||||
Other | 0 | |||||
Net income | $ 81 | 81 | ||||
Cumulative effect adjustment to accumulated deficit related to the adoption of ASU 2016-01, Financial Instruments | 2 | |||||
Cumulative effect adjustment to accumulated deficit related to the adoption of ASU 2016-01, Financial Instruments | Accounting Standards Update 2016-01 | 2 | |||||
Other comprehensive income (loss) | (3) | (3) | ||||
Ending balance at Mar. 31, 2018 | 715 | 10 | 8,502 | (108) | (7,692) | 3 |
Beginning balance at Dec. 29, 2018 | 1,266 | 10 | 8,750 | (50) | (7,436) | (8) |
Changes in Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||||||
Common stock issued under employee equity incentive plans, net of tax withholding | 0 | 1 | ||||
Issuance of common stock upon warrant exercise | 1 | 448 | ||||
Stock-based compensation | 41 | |||||
Issuance of treasury stock to partially settle debt | 5 | 2 | ||||
Other | 1 | |||||
Net income | 16 | 16 | ||||
Cumulative effect adjustment to accumulated deficit related to the adoption of ASU 2016-01, Financial Instruments | 0 | |||||
Cumulative effect adjustment to accumulated deficit related to the adoption of ASU 2016-01, Financial Instruments | Accounting Standards Update 2016-01 | 0 | |||||
Other comprehensive income (loss) | 7 | 7 | ||||
Ending balance at Mar. 30, 2019 | $ 1,788 | $ 11 | $ 9,246 | $ (48) | $ (7,420) | $ (1) |
Basis of Presentation and Signi
Basis of Presentation and Significant Accounting Policies | 3 Months Ended |
Mar. 30, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation and Significant Accounting Policies | Basis of Presentation and Significant Accounting Policies Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Advanced Micro Devices, Inc. and its subsidiaries (the Company or AMD) have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The results of operations for the three months ended March 30, 2019 shown in this report are not necessarily indicative of results to be expected for the full year ending December 28, 2019 . In the opinion of the Company’s management, the information contained herein reflects all adjustments necessary for a fair presentation of the Company’s results of operations, financial position, cash flows and s tockholders' equity . All such adjustments are of a normal, recurring nature. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended December 29, 2018. All periods presented conform to the current period presentation. The Company uses a 52 or 53 week fiscal year ending on the last Saturday in December. The three months ended March 30, 2019 and March 31, 2018 each consisted of 13 weeks. Principles of Consolidation. The condensed consolidated financial statements include the Company’s accounts and those of its wholly-owned subsidiaries. Upon consolidation, all significant inter-company accounts and transactions are eliminated. Significant Accounting Policies. Except for the accounting policies highlighted below, there have been no material changes to the Company's significant accounting policies in Note 2 - Summary of Significant Accounting Policies, of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended December 29, 2018. Leases. The Company determines if an arrangement is a lease, or contains a lease, at the inception of the arrangement. When the Company determines the arrangement is a lease, or contains a lease, at lease inception, it then determines whether the lease is an operating lease or a finance lease at the commencement date. Operating and finance leases result in the Company recording a right-of-use (ROU) asset and lease liability on its balance sheet. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. Operating and finance lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. In determining the present value of lease payments, the Company uses the implicit interest rate if readily determinable. When the implicit rate is not readily determinable, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The operating lease ROU asset is recognized net of any lease payments made and any lease incentives. Specific lease terms may include options to extend or terminate the lease when the Company believes it is reasonably certain that it will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. As allowed by the guidance, the Company has elected not to recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases for any class of underlying asset. Operating leases are included in operating lease ROU assets, other current liabilities, and long-term operating lease liabilities in the Company's condensed consolidated balance sheet. The Company's finance leases are immaterial. Derivative Financial Instruments. The Company maintains a foreign currency hedging strategy which uses derivative financial instruments to mitigate the risks associated with changes in foreign currency exchange rates. This strategy takes into consideration all of the Company’s consolidated exposures. The Company does not use derivative financial instruments for trading or speculative purposes. In applying its strategy, the Company uses foreign currency forward contracts to hedge certain forecasted expenses denominated in foreign currencies. The Company designates these contracts as cash flow hedges of forecasted expenses, to the extent eligible under the accounting rules, and evaluates hedge effectiveness prospectively and retrospectively. As such, the effective portion of the gain or loss on these contracts is reported as a component of accumulated other comprehensive income (loss) and is reclassified to earnings in the same line item as the associated forecasted transaction and in the same period during which the hedged transaction affects earnings. For periods prior to the three months ended March 30, 2019, any ineffective portion was immediately recorded in Other income (expense), net. As a result of adopting ASU 2017-12, Derivatives and Hedging (ASC 815): Targeted Improvements to Accounting for Hedging Activities (ASU 2017-12) , beginning in January 2019, the ineffective portion will be held in accumulated other comprehensive income (loss) until the associated forecasted transaction affects earnings and such amounts are included in the same line item in earnings as the associated forecasted transaction. The Company also uses, from time to time, foreign currency forward contracts to economically hedge recognized foreign currency exposures on the balance sheets of various subsidiaries. The Company does not designate these forward contracts as hedging instruments. Accordingly, the gain or loss associated with these contracts is immediately recorded in earnings. Recently Adopted Accounting Standards Fair Value Measurement. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (ASC 820) , which amends disclosure requirements for fair value measurement. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods therein with early adoption permitted. The Company early adopted this guidance in the first quarter of 2019 with no material impact on its consolidated financial statements. Leases. In February 2016, the FASB issued ASU 2016-02, Leases (ASC 842) , to increase transparency and comparability among organizations for lease recognition and disclosure. ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet, while recognizing expenses on the income statements in a manner similar to legacy guidance. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018. The Company adopted the new standard using the optional adoption method in the first quarter of 2019, whereby the Company did not have to adjust comparative period financial statements for the new standard and recorded $228 million of right-of-use assets and $261 million of lease liabilities primarily related to office buildings in its consolidated balance sheet as of December 30, 2018. The Company's accounting for capital leases, now referred to as finance leases, remains substantially unchanged. The Company's adoption of the new standard had no impact on its consolidated statement of operations or on net cash provided by or used in operating, financing, or investing activities on its consolidated statement of cash flows. Upon adoption, the Company elected a transition practical expedient under the new accounting standard allowing it not to separate lease and non-lease components and instead to account for each separate lease component and non-lease component as a single lease component. The Company implemented internal controls and key system functionality to enable the preparation of financial information on adoption. Reporting Comprehensive Income . In February 2018, the FASB issued ASU 2018-02, Income Statement — Reporting Comprehensive Income (ASC 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI) , which allows companies to reclassify certain tax effects resulting from the 2017 Tax Cuts and Jobs Act (Tax Act), from accumulated other comprehensive income to retained earnings. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018. The Company adopted this guidance in the first quarter of 2019 with no impact on its consolidated financial statements. Derivatives and Hedging. In August 2017, the FASB issued ASU 2017-12, which amends and simplifies existing guidance to allow companies to more accurately present the economic effects of risk management activities in the financial statements. ASU 2017-12 is effective for fiscal years beginning after December 15, 2018. The Company adopted this guidance in the first quarter of 2019 with no material impact on its consolidated financial statements. Recently Issued Accounting Standards There were no other significant updates to the recently issued accounting standards other than as disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 29, 2018. Although there are several other new accounting pronouncements issued or proposed by the FASB, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its consolidated financial position or operating results. |
GLOBALFOUNDRIES
GLOBALFOUNDRIES | 3 Months Ended |
Mar. 30, 2019 | |
Related Party Transactions [Abstract] | |
GLOBALFOUNDRIES | GLOBALFOUNDRIES Wafer Supply Agreement. In March 2009, the Company and GLOBALFOUNDRIES Inc. (GF) entered into a Wafer Supply Agreement (the WSA) under which, among other terms, the Company would purchase wafers from GF. The WSA, which has been amended from time to time, governs the terms by which the Company purchases products manufactured by GF. Seventh Amendment to Wafer Supply Agreement. On January 28, 2019, the Company entered into a seventh amendment (the Seventh Amendment) to the WSA with GF. The Seventh Amendment modifies certain purchase commitments, pricing and other terms of the WSA applicable to wafer purchases at the 12 nm technology node and above by the Company for the period commencing on January 1, 2019 and continuing through March 1, 2024. The Seventh Amendment also provides the Company with full flexibility to contract with any wafer foundry with respect to all products manufactured using 7nm and smaller technology nodes without any one-time payments or royalties by the Company to GF. Further, the Company and GF agreed to modify the annual wafer purchase targets previously agreed to for years 2019 and 2020. The parties also agreed to an annual wafer purchase target for 2021 and agreed to pricing for wafers purchased for years 2019, 2020 and 2021. If the Company does not meet the annual wafer purchase target for any of these years, the Company will be required to pay to GF a portion of the difference between the Company’s actual wafer purchases and the wafer purchase target for that year. The Company expects that its future purchases from GF will be material under the WSA, which is in place until March 1, 2024. The Company also agreed to continue to make quarterly payments to GF based on the volume of certain wafers purchased from another wafer foundry. The Company’s total purchases from GF related to wafer manufacturing, research and development activities and other during the three months ended March 30, 2019 and March 31, 2018 were $378 million and $398 million , respectively. Included in the total purchases during the three months ended March 30, 2019 were amounts related to the volume of certain wafers purchased from another wafer foundry, as agreed by the Company and GF. As of March 30, 2019 and December 29, 2018 , the amount of prepayment and other receivables related to GF was $12 million and $18 million , respectively, included in Prepayment and receivables—related parties on the Company’s condensed consolidated balance sheets. As of March 30, 2019 and December 29, 2018 , the amount of payable to GF was $246 million and $326 million , respectively, included in Payables to related parties on the Company’s condensed consolidated balance sheets. Warrant Agreement . On August 30, 2016, in consideration for the limited waiver and rights under the WSA Sixth Amendment, the Company entered into a warrant agreement (the Warrant Agreement) with West Coast Hitech L.P. (WCH), a wholly-owned subsidiary of Mubadala Development Company PJSC (Mubadala). Under the Warrant Agreement, WCH and its permitted assigns were entitled to purchase 75 million shares of the Company’s common stock (the Warrant Shares) at a purchase price of $5.98 per share. During the three months ended March 30, 2019, WCH exercised its warrant to purchase 75 million shares of the Company’s common stock at a purchase price of $5.98 per share for a total amount of $448.5 million . GF continues to be a related party of the Company because Mubadala and Mubadala Technology Investments LLC (Mubadala Tech, a party to the WSA) are affiliated with WCH, and a member of the Company's Board of Directors is associated with Mubadala. GF, WCH and Mubadala Tech are wholly-owned subsidiaries of Mubadala. |
Supplemental Balance Sheet Info
Supplemental Balance Sheet Information | 3 Months Ended |
Mar. 30, 2019 | |
Balance Sheet Related Disclosures [Abstract] | |
Supplemental Balance Sheet Information | Supplemental Balance Sheet Information Accounts Receivable, net As of March 30, 2019 and December 29, 2018 , Accounts receivable, net included unbilled accounts receivable of $353 million and $308 million , respectively. Unbilled receivables primarily represent work completed on semi-custom products under non-cancellable purchase orders that have no alternative use to the Company at contract inception, for which revenue has been recognized but not yet invoiced to customers. All unbilled accounts receivable are expected to be billed and collected within twelve months. Inventories, net March 30, December 29, (In millions) Raw materials $ 120 $ 134 Work in process 548 354 Finished goods 287 357 Total inventories, net $ 955 $ 845 Property and Equipment, net March 30, December 29, (In millions) Leasehold improvements $ 181 $ 179 Equipment 808 798 Construction in progress 112 78 Property and equipment, gross 1,101 1,055 Accumulated depreciation (724 ) (707 ) Total property and equipment, net $ 377 $ 348 Other Assets March 30, December 29, (In millions) Software technology and licenses, net $ 222 $ 226 Other 95 95 Total other assets $ 317 $ 321 Accrued Liabilities March 30, December 29, (In millions) Accrued compensation and benefits $ 226 $ 236 Marketing programs and advertising expenses 241 275 Software technology and licenses payable 56 28 Other 196 224 Total accrued liabilities $ 719 $ 763 Other Current Liabilities March 30, December 29, (In millions) Unearned revenue $ 2 $ 11 Operating lease liabilities 38 — Other 5 13 Total other current liabilities $ 45 $ 24 Unearned revenue represents consideration received or due from customers in advance of the Company satisfying its performance obligations. The unearned revenue is associated with any combination of development services, IP licensing and product revenue. Changes in unearned revenue were as follows: Three Months Ended March 30, March 31, (In millions) Beginning balance $ 11 $ 85 Unearned revenue 1 86 Revenue recognized during the period (10 ) (24 ) Ending balance $ 2 $ 147 Revenue allocated to remaining performance obligations that are unsatisfied (or partially unsatisfied) as of March 30, 2019 is $70 million , which may include amounts received from customers but not yet earned and amounts that will be invoiced and recognized as revenue in future periods associated with any combination of development services, IP licensing and product revenue. The Company expects to recognize $70 million in the next 12 months. The revenue allocated to remaining performance obligations did not include amounts which have an original contractual expected duration of less than one year. |
Equity Interest Purchase Agreem
Equity Interest Purchase Agreement - ATMP Joint Venture | 3 Months Ended |
Mar. 30, 2019 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Equity Interest Purchase Agreement - ATMP Joint Venture | Equity Interest Purchase Agreement - ATMP Joint Venture The Company holds a 15% equity interest in two joint ventures (collectively, the ATMP JV). The Company has no obligation to fund the ATMP JV. The Company accounts for its equity interests in the ATMP JV under the equity method of accounting due to its significant influence over the ATMP JV. As of March 30, 2019 and December 29, 2018 , the carrying value of the Company’s investment in the ATMP JV was $57 million and $58 million , respectively. The ATMP JV is a related party of the Company. The ATMP JV provides assembly, test, mark and packaging (ATMP) services to the Company. The Company currently pays the ATMP JV for ATMP services on a cost-plus basis. The Company assists the ATMP JV in its management of certain raw material inventory. The purchases from and resales to the ATMP JV of inventory under inventory management is reported within purchases and resales with the ATMP JV and does not impact the Company’s condensed consolidated statement of operations. The Company’s total purchases from the ATMP JV during the three months ended March 30, 2019 and March 31, 2018 amounted to $132 million and $135 million , respectively. As of March 30, 2019 and December 29, 2018 , the amount payable to the ATMP JV was $201 million and $207 million , respectively, included in Payables to related parties on the Company ’ s condensed consolidated balance sheets. The Company’s resales back to the ATMP JV during the three months ended March 30, 2019 and March 31, 2018 amounted to $ 26 million and $ 6 million , respectively. As of March 30, 2019 and December 29, 2018 , the Company had receivables from ATMP JV of $25 million and $16 million , respectively, included in Prepayment and receivables—related parties on the Company’s condensed consolidated balance sheets. For both the three months ended March 30, 2019 and March 31, 2018 , the Company recorded $1 million in Equity loss in investee on its condensed consolidated statements of operations, which included certain expenses incurred by the Company on behalf of the ATMP JV. Equity Joint Venture In February 2016, the Company and Higon Information Technology Co., Ltd. (THATIC), a third-party Chinese entity (JV Partner), formed a joint venture comprised of two separate legal entities, China JV1 and China JV2 (collectively, the THATIC JV). The Company’s equity share in China JV1 and China JV2 is a majority and minority interest, respectively, funded by the Company’s contribution of certain of its patents. The JV Partner is responsible for the initial and on-going financing of the THATIC JV’s operations. The Company has no obligations to fund the THATIC JV. The Company concluded the China JV1 and China JV2 are not operating joint ventures and are variable interest entities due to their reliance on on-going financing by the JV Partner. The Company determined that it is not the primary beneficiary of either China JV1 or China JV2, as the Company does not have unilateral power to direct selling and marketing, manufacturing and product development activities related to the THATIC JV’s products. Accordingly, the Company does not consolidate either of these entities and therefore accounts for its investments in the THATIC JV under the equity method of accounting. The THATIC JV is a related party of the Company. The Company’s share in the net losses of the THATIC JV for the three months ended March 30, 2019 was not material and is not recorded in the Company’s condensed consolidated statements of operations since the Company is not obligated to fund the THATIC JV’s losses in excess of the Company’s investment in the THATIC JV, which was zero as of March 30, 2019. As of March 30, 2019 and December 29, 2018, the total assets and liabilities of the THATIC JV were not material. In February 2016, the Company licensed certain of its intellectual property (Licensed IP) to the THATIC JV for a total of $293 million in license fees payable over several years contingent upon achievement of certain milestones. The Company also expects to receive a royalty based on the sales of the THATIC JV’s products to be developed on the basis of such Licensed IP. The Company classifies Licensed IP income and royalty income, associated with the February 2016 agreement, as licensing gain within other operating income. For the three months ended March 30, 2019 , the Company recognized $60 million as licensing gain associated with the Licensed IP. In March 2017, the Company entered into a development and intellectual property agreement (Development and IP) with the THATIC JV, and also expects to receive a royalty based on the sales of the THATIC JV’s products to be developed on the basis of such agreement. The Company classifies Development and IP income and royalty income, associated with the March 2017 agreement, as revenue once earned. In addition, from time to time, the Company enters into certain agreements with the THATIC JV to provide other services primarily related to research and development. The Company’s receivable from the THATIC JV for the above agreements was $13 million and $18 million as of March 30, 2019 and December 29, 2018 , respectively, included in Prepayment and receivables—related parties on its condensed consolidated balance sheets. |
Equity Joint Venture
Equity Joint Venture | 3 Months Ended |
Mar. 30, 2019 | |
Equity Method Investments and Joint Ventures [Abstract] | |
Equity Joint Venture | Equity Interest Purchase Agreement - ATMP Joint Venture The Company holds a 15% equity interest in two joint ventures (collectively, the ATMP JV). The Company has no obligation to fund the ATMP JV. The Company accounts for its equity interests in the ATMP JV under the equity method of accounting due to its significant influence over the ATMP JV. As of March 30, 2019 and December 29, 2018 , the carrying value of the Company’s investment in the ATMP JV was $57 million and $58 million , respectively. The ATMP JV is a related party of the Company. The ATMP JV provides assembly, test, mark and packaging (ATMP) services to the Company. The Company currently pays the ATMP JV for ATMP services on a cost-plus basis. The Company assists the ATMP JV in its management of certain raw material inventory. The purchases from and resales to the ATMP JV of inventory under inventory management is reported within purchases and resales with the ATMP JV and does not impact the Company’s condensed consolidated statement of operations. The Company’s total purchases from the ATMP JV during the three months ended March 30, 2019 and March 31, 2018 amounted to $132 million and $135 million , respectively. As of March 30, 2019 and December 29, 2018 , the amount payable to the ATMP JV was $201 million and $207 million , respectively, included in Payables to related parties on the Company ’ s condensed consolidated balance sheets. The Company’s resales back to the ATMP JV during the three months ended March 30, 2019 and March 31, 2018 amounted to $ 26 million and $ 6 million , respectively. As of March 30, 2019 and December 29, 2018 , the Company had receivables from ATMP JV of $25 million and $16 million , respectively, included in Prepayment and receivables—related parties on the Company’s condensed consolidated balance sheets. For both the three months ended March 30, 2019 and March 31, 2018 , the Company recorded $1 million in Equity loss in investee on its condensed consolidated statements of operations, which included certain expenses incurred by the Company on behalf of the ATMP JV. Equity Joint Venture In February 2016, the Company and Higon Information Technology Co., Ltd. (THATIC), a third-party Chinese entity (JV Partner), formed a joint venture comprised of two separate legal entities, China JV1 and China JV2 (collectively, the THATIC JV). The Company’s equity share in China JV1 and China JV2 is a majority and minority interest, respectively, funded by the Company’s contribution of certain of its patents. The JV Partner is responsible for the initial and on-going financing of the THATIC JV’s operations. The Company has no obligations to fund the THATIC JV. The Company concluded the China JV1 and China JV2 are not operating joint ventures and are variable interest entities due to their reliance on on-going financing by the JV Partner. The Company determined that it is not the primary beneficiary of either China JV1 or China JV2, as the Company does not have unilateral power to direct selling and marketing, manufacturing and product development activities related to the THATIC JV’s products. Accordingly, the Company does not consolidate either of these entities and therefore accounts for its investments in the THATIC JV under the equity method of accounting. The THATIC JV is a related party of the Company. The Company’s share in the net losses of the THATIC JV for the three months ended March 30, 2019 was not material and is not recorded in the Company’s condensed consolidated statements of operations since the Company is not obligated to fund the THATIC JV’s losses in excess of the Company’s investment in the THATIC JV, which was zero as of March 30, 2019. As of March 30, 2019 and December 29, 2018, the total assets and liabilities of the THATIC JV were not material. In February 2016, the Company licensed certain of its intellectual property (Licensed IP) to the THATIC JV for a total of $293 million in license fees payable over several years contingent upon achievement of certain milestones. The Company also expects to receive a royalty based on the sales of the THATIC JV’s products to be developed on the basis of such Licensed IP. The Company classifies Licensed IP income and royalty income, associated with the February 2016 agreement, as licensing gain within other operating income. For the three months ended March 30, 2019 , the Company recognized $60 million as licensing gain associated with the Licensed IP. In March 2017, the Company entered into a development and intellectual property agreement (Development and IP) with the THATIC JV, and also expects to receive a royalty based on the sales of the THATIC JV’s products to be developed on the basis of such agreement. The Company classifies Development and IP income and royalty income, associated with the March 2017 agreement, as revenue once earned. In addition, from time to time, the Company enters into certain agreements with the THATIC JV to provide other services primarily related to research and development. The Company’s receivable from the THATIC JV for the above agreements was $13 million and $18 million as of March 30, 2019 and December 29, 2018 , respectively, included in Prepayment and receivables—related parties on its condensed consolidated balance sheets. |
Debt and Secured Revolving Line
Debt and Secured Revolving Line of Credit | 3 Months Ended |
Mar. 30, 2019 | |
Debt Disclosure [Abstract] | |
Debt and Secured Revolving Line of Credit | Debt and Secured Revolving Line of Credit Debt 2.125% Convertible Senior Notes Due 2026 In September 2016, the Company issued $805 million , in aggregate, principal amount of 2.125% Convertible Senior Notes due 2026 ( 2.125% Notes). The 2.125% Notes are general unsecured senior obligations of the Company. The interest is payable semi-annually in March and September of each year, commencing in March 2017. As of March 30, 2019 , the Company had $805 million principal amount outstanding. The 2.125% Notes mature on September 1, 2026. However, as outlined in the indenture governing the 2.125% Notes, holders of the 2.125% Notes may convert them at their option during certain time periods and upon the occurrence of one of the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2016 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day (equivalent to an initial conversion price of approximately $8.00 per share of common stock); (2) during the five business day period after any ten consecutive trading day period (the Measurement Period) in which the trading price per $1,000 principal amount of notes for each trading day of the Measurement Period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events. On or after June 1, 2026 until the close of business on the business day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election. The first event described in (1) above was met during the first quarter of 2019 and as a result, the 2.125% Notes are convertible at the option of the holder from April 1, 2019 until June 30, 2019. The Company’s current intent is to deliver shares of its common stock upon conversion of the 2.125% Notes. As such, the Company continued to classify the carrying value of the liability component of the 2.125% Notes as long-term debt and the equity component of the 2.125% Notes as permanent equity on its condensed consolidated balance sheet as of March 30, 2019 . The 2.125% Notes consisted of the following: March 30, December 29, (In millions) Principal amounts: Principal $ 805 $ 805 Unamortized debt discount (1) (256 ) (262 ) Unamortized debt issuance costs (10 ) (11 ) Net carrying amount $ 539 $ 532 Carrying amount of the equity component, net (2) $ 305 $ 305 (1) Included in the consolidated balance sheets within Long-term debt, net and amortized over the remaining life of the notes using the effective interest rate method. (2) Included in the consolidated balance sheets within additional paid-in capital, net of $9 million of equity issuance costs. As of March 30, 2019 , the remaining life of the 2.125% Notes was approximately 90 months . Based on the closing price of the Company’s common stock of $25.52 on March 29, 2019, the last trading day of the three months ended March 30, 2019 , the if-converted value of the 2.125% Notes exceeded its principal amount by $1,763 million . The effective interest rate of the liability component of the 2.125% Notes is 8% . This interest rate was based on the interest rates of similar liabilities at the time of issuance that did not have associated conversion features. The following table sets forth total interest expense recognized related to the 2.125% Notes: Three Months Ended March 30, March 31, (In millions) Contractual interest expense $ 4 $ 4 Interest cost related to amortization of the debt discount $ 6 $ 6 6.75% Senior Notes Due 2019 On February 26, 2014, the Company issued $600 million of its 6.75% Senior Notes due March 1, 2019 ( 6.75% Notes). The 6.75% Notes were general unsecured senior obligations of the Company. Interest was payable on March 1 and September 1 of each year beginning September 1, 2014 until the maturity date of March 1, 2019. During the three months ended March 30, 2019 , the Company redeemed the remaining $66 million in aggregate principal amount of its 6.75% Notes with a combination of cash and treasury stock. 7.50% Senior Notes Due 2022 On August 15, 2012, the Company issued $500 million of its 7.50% Senior Notes due 2022 ( 7.50% Notes). The 7.50% Notes are general unsecured senior obligations of the Company. Interest is payable on February 15 and August 15 of each year beginning February 15, 2013 until the maturity date of August 15, 2022. The 7.50% Notes are governed by the terms of an indenture (the 7.50% Indenture) dated August 15, 2012 between the Company and Wells Fargo Bank, N.A., as trustee. During the three months ended March 30, 2019 , the Company repurchased $25 million in aggregate principal amount of its 7.50% Notes in cash. As of March 30, 2019 , the outstanding aggregate principal amount of the 7.50% Notes was $312 million . 7.00% Senior Notes Due 2024 On June 16, 2014, the Company issued $500 million of its 7.00% Senior Notes due 2024 ( 7.00% Notes). The 7.00% Notes are general unsecured senior obligations of the Company. Interest is payable on January 1 and July 1 of each year beginning January 1, 2015 until the maturity date of July 1, 2024. The 7.00% Notes are governed by the terms of an indenture (the 7.00% Indenture) dated June 16, 2014 between the Company and Wells Fargo Bank, N.A., as trustee. During the three months ended March 30, 2019 , the Company repurchased $74 million in aggregate principal amount of its 7.00% Notes with a combination of cash and treasury stock. As of March 30, 2019 , the outstanding aggregate principal amount of the 7.00% Notes was $176 million . For the three months ended March 30, 2019 , the Company recorded an $8 million loss on extinguishment of debt associated with the debt redemption and repurchases noted above. Potential Repurchase of Outstanding Notes The Company may elect to purchase or otherwise retire the 7.50% Notes and 7.00% Notes with cash or other assets and the 2.125% Notes with stock from time to time in the open market or through privately negotiated transactions, either directly or through intermediaries, or by tender offer when the Company believes the market conditions are favorable. Secured Revolving Line of Credit The Company, a group of lenders and Bank of America N.A., acting as the agent for the lenders, are parties to an amended and restated loan and security agreement, as amended (the Agreement). The Agreement provides for a secured revolving line of credit (the Secured Revolving Line of Credit) that allows the Company to borrow, repay and re-borrow amounts from time to time up to $500 million with up to $45 million available for issuance of letters of credit, subject to certain conditions. The Secured Revolving Line of Credit is limited up to a certain amount of eligible accounts receivable, as determined in accordance with the Agreement. The size of the commitment under the Secured Revolving Line of Credit may be increased by up to an aggregate amount of $200 million . The commitments under the Secured Revolving Line of Credit are available through March 21, 2022. The Company is subject to commitment fees and letter of credit facility fees and is are required to comply with certain covenants under the Agreement. The Secured Revolving Line of Credit bears interest, at the option of the Company, either at (a) a customary London Interbank Offered Rate (LIBOR) plus an applicable margin (as determined in accordance with the agreement), or (b) (i) the greatest of (x) the bank’s prime rate, (y) the federal funds rate as published by the Federal Reserve Bank of New York plus 0.50% , and (z) LIBOR for a one-month period plus 1.00% , plus (ii) an applicable margin. As of March 30, 2019 and December 29, 2018 , the Secured Revolving Line of Credit had an outstanding loan balance of $70 million , at an interest rate of 6.00% and 6.00% , respectively. As of March 30, 2019 , the Company had $26 million of letters of credit outstanding and up to $119 million available for future borrowings under the Secured Revolving Line of Credit. The Company reports its intra-period changes in its revolving credit balance on a net basis in its condensed consolidated statement of cash flows as the Company intends the period of the borrowings to be brief, repaying borrowed amounts within 90 days . As of March 30, 2019 , the Company was in compliance with all required covenants under the Agreement. |
Earnings Per Share
Earnings Per Share | 3 Months Ended |
Mar. 30, 2019 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | Earnings Per Share Basic earnings per share is computed based on the weighted average number of common shares outstanding. Diluted earnings per share is computed based on the weighted average number of common shares outstanding plus potentially dilutive shares outstanding during the period using the average market price for the respective period. Potentially dilutive shares are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed exercise of the warrant under the Warrant Agreement with WCH prior to the exercise of the warrant on February 13, 2019. Potentially dilutive shares issuable upon conversion of the 2.125% Notes are calculated using the if-converted method. The following table sets forth the components of basic and diluted earnings per share: Three Months Ended March 30, March 31, (In millions, except per share amounts) Numerator Net income $ 16 $ 81 Denominator Basic weighted-average shares 1,044 968 Effect of potentially dilutive shares: Employee equity incentive plans and warrants 50 71 Diluted weighted-average shares 1,094 1,039 Earnings per share: Basic $ 0.01 $ 0.08 Diluted $ 0.01 $ 0.08 Potential shares from employee equity incentive plans and the conversion of the 2.125% Notes totaling 103 million for both the three months ended March 30, 2019 and March 31, 2018 were not included in the earnings per share calculation because their inclusion would have been anti-dilutive. |
Financial Instruments
Financial Instruments | 3 Months Ended |
Mar. 30, 2019 | |
Investments, Debt and Equity Securities [Abstract] | |
Financial Instruments | Financial Instruments Cash, Cash Equivalents, and Marketable Securities Cash and financial instruments measured and recorded at fair value as of March 30, 2019 and December 29, 2018 are summarized below: Total Fair Cash and Short-Term Marketable Securities (In millions) March 30, 2019 Cash $ 630 $ 630 $ — Level 1 (1) Government money market funds $ 5 $ 5 $ — Total level 1 $ 5 $ 5 $ — Level 2 (2) Commercial paper $ 559 $ 343 $ 216 Total level 2 $ 559 $ 343 $ 216 Total $ 1,194 $ 978 $ 216 Total Fair Cash and Short-Term Marketable Securities (In millions) December 29, 2018 Cash $ 315 $ 315 $ — Level 1 (1) Government money market funds $ 275 $ 275 $ — Total level 1 $ 275 $ 275 $ — Level 2 (2) Commercial paper $ 566 $ 488 $ 78 Total level 2 $ 566 $ 488 $ 78 Total $ 1,156 $ 1,078 $ 78 (1) The Company ’ s Level 1 assets are valued using quoted prices for identical instruments in active markets. (2) The Company’s Level 2 assets are valued using broker reports that utilize quoted prices for identical instruments in markets that are not active or comparable instruments in active markets. Brokers gather observable inputs for all of the Company’s fixed income securities from a variety of industry data providers and other third-party sources. In addition to those amounts presented above, as of both March 30, 2019 and December 29, 2018 , the Company had $5 million of investments in government money market funds, used as collateral for letters of credit deposits, which were included in Other current assets on the Company’s condensed consolidated balance sheets. These government money market funds are classified within Level 1 because they are valued using quoted prices for identical instruments in active markets. Their amortized cost approximates the fair value for all periods presented. As of March 30, 2019 and December 29, 2018 , the Company also had $22 million and $21 million , respectively, of investments in mutual funds held in a Rabbi trust established for the Company’s deferred compensation plan, which were included in Other assets on the Company’s condensed consolidated balance sheets. These mutual funds are classified within Level 1 because they are valued using quoted prices for identical instruments in active markets. Their amortized cost approximates the fair value for all periods presented. The Company is restricted from accessing these investments. Financial Instruments Not Recorded at Fair Value on a Recurring Basis. The Company carries its financial instruments at fair value with the exception of its debt. Financial instruments that are not recorded at fair value are measured at fair value on a quarterly basis for disclosure purposes. The carrying amounts and estimated fair values of financial instruments not recorded at fair value are as follows: March 30, 2019 December 29, 2018 Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value (In millions) Short-term debt, net $ 70 $ 70 $ 136 $ 136 Long-term debt, net (1) $ 1,024 $ 3,147 $ 1,114 $ 2,428 (1) Carrying amounts of long-term debt are net of unamortized debt issuance costs of $14 million as of March 30, 2019 and $16 million as of December 29, 2018 , and net of unamortized debt discount associated with the 2.125% Notes of $256 million as of March 30, 2019 and $262 million as of December 29, 2018 . The Company’s long-term debt is classified within Level 2. The fair value of the debt was estimated based on the quoted market prices for the same or similar issues or on the current rates offered to the Company for debt of the same remaining maturities. The Company’s 2.125% Notes, included in Long-term debt, net above, were convertible at the option of the holder as of March 30, 2019. The estimated fair value of the 2.125% Notes take into account the value between the Company’s stock price as of the end of the quarter and the equivalent initial conversion price of approximately $8.00 per share of common stock. The fair value of the Company’s accounts receivable, accounts payable and other short-term obligations approximate their carrying value based on existing payment terms. Hedging Transactions and Derivative Financial Instruments Cash Flow Hedges and Foreign Currency Forward Contracts not Designated as Hedges The following table shows the impact of gains (losses) resulting from cash flow hedges and foreign currency forward contracts not designated as hedges on the respective condensed consolidated statement of operations line items: Gains (Losses) Recognized in Income Three Months Ended March 30, March 31, Research and development Marketing, general and administrative Other income (expense), net Research and development Marketing, general and administrative Other income (expense), net (In millions) Total amounts presented in the condensed consolidated statements of operations in which the effects of cash flow hedges were recorded $ 373 $ 170 $ (7 ) $ 343 $ 134 $ 1 Foreign Currency Forward Contracts - gains (losses) Contracts designated as cash flow hedging instruments Gains (losses) reclassified from OCI into income (2 ) — — 3 1 — Contracts not designated as hedging instruments Gains (losses) recognized in income — — — — — (2 ) Total Gains (losses) $ (2 ) $ — $ — $ 3 $ 1 $ (2 ) For foreign currency contracts designated as cash flow hedges, the amounts excluded from the assessment of hedge effectiveness were immaterial. The Company’s foreign currency derivative contracts are classified within Level 2 because the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, such as currency spot and forward rates. The following table shows the fair value amounts included in Other current assets should the foreign currency forward contracts be in a gain position or included in Other current liabilities should these contracts be in a loss position. These amounts were recorded in the Company’s condensed consolidated balance sheets as follows: March 30, December 29, (In millions) Foreign Currency Forward Contracts - gains (losses) Contracts designated as cash flow hedging instruments - Gain $ 3 $ 8 Contracts designated as cash flow hedging instruments - Loss $ (3 ) $ (1 ) As of March 30, 2019 and December 29, 2018 , the notional values of the Company’s outstanding foreign currency forward contracts were $517 million and $396 million , respectively. All the contracts mature within 12 months, and, upon maturity, the amounts recorded in Accumulated other comprehensive income (loss) are expected to be reclassified into earnings. The Company hedges its exposure to the variability in future cash flows for forecasted transactions over a maximum of 12 months. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 30, 2019 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes For the three months ended March 30, 2019 , the Company recorded an income tax benefit of $13 million associated with a credit to U.S. taxes due to the completion of certain internal tax structuring. For the three months ended March 31, 2018 , the Company recorded an income tax provision of $8 million , consisting primarily of $5 million for U.S. taxes and $3 million of foreign taxes in profitable locations. As of March 30, 2019 , substantially all of the Company’s U.S. and Canadian deferred tax assets, net of deferred tax liabilities, continue to be subject to a valuation allowance. The realization of these assets is dependent on substantial future taxable income which, as of March 30, 2019 , in management’s estimate, is not more likely than not to be achieved. The Company’s total gross unrecognized tax benefits were $50 million as of March 30, 2019 . The Company does not believe it is reasonably possible that unrecognized tax benefits will materially change in the next 12 months. However, the settlement, resolution or closure of tax audits are highly uncertain. |
Segment Reporting
Segment Reporting | 3 Months Ended |
Mar. 30, 2019 | |
Segment Reporting [Abstract] | |
Segment Reporting | Segment Reporting Management, including the Chief Operating Decision Maker, who is the Company’s Chief Executive Officer, reviews and assesses operating performance using segment net revenue and operating income before interest, other income (expense), net and income taxes. These performance measures include the allocation of expenses to the operating segments based on management’s judgment. The Company has the following two reportable segments: • the Computing and Graphics segment, which primarily includes desktop and notebook processors and chipsets, discrete and integrated graphics processing units (GPUs), and datacenter and professional GPUs. The Company also licenses portions of its IP portfolio; and • the Enterprise, Embedded and Semi-Custom segment, which primarily includes server and embedded processors, semi-custom System-on-Chip (SoC) products, development services and technology for game consoles. The Company also licenses portions of its IP portfolio. In addition to these reportable segments, the Company has an All Other category, which is not a reportable segment. This category primarily includes certain expenses and credits that are not allocated to any of the reportable segments because management does not consider these expenses and credits in evaluating the performance of the reportable segments. This category also includes employee stock-based compensation expense. The following table provides a summary of net revenue and operating income by segment: Three Months Ended March 30, March 31, (In millions) Net revenue: Computing and Graphics $ 831 $ 1,115 Enterprise, Embedded and Semi-Custom 441 532 Total net revenue $ 1,272 $ 1,647 Operating income (loss): Computing and Graphics $ 16 $ 138 Enterprise, Embedded and Semi-Custom 68 14 All Other (1) (46 ) (32 ) Total operating income $ 38 $ 120 (1) All Other operating losses consisted of $41 million of stock-based compensation expense and a $5 million contingent loss in connection with a legal matter for the three months ended March 30, 2019 and $32 million stock-based compensation expense for the three months ended March 31, 2018 . |
Stock-Based Incentive Compensat
Stock-Based Incentive Compensation Plans | 3 Months Ended |
Mar. 30, 2019 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock-Based Incentive Compensation Plans | Stock-Based Incentive Compensation Plans Restricted Stock Units During the three months ended March 30, 2019 and March 31, 2018 , the Company granted 0.8 million and 2.2 million of restricted stock units, including an immaterial number of performance-based restricted stock units (PRSUs) with market conditions, with weighted average grant date fair value per share of $24.32 and $12.17 , respectively. For the three months ended March 30, 2019 and March 31, 2018 , the Company recorded stock-based compensation expense under employee equity incentive plans of $41 million and $32 million , respectively. |
Contingencies
Contingencies | 3 Months Ended |
Mar. 30, 2019 | |
Commitments and Contingencies Disclosure [Abstract] | |
Contingencies | Contingencies Wessels, Hamilton and Ha Shareholder Derivative Lawsuits On March 20, 2014, a purported shareholder derivative lawsuit captioned Wessels v. Read, et al. , Case No. 1:14 cv-262486 (Wessels) was filed against the Company (as a nominal defendant only) and certain of its directors and officers in the Santa Clara County Superior Court of the State of California. The complaint purports to assert claims against the Company and certain individual directors and officers for breach of fiduciary duty, waste of corporate assets and unjust enrichment. The complaint seeks damages allegedly caused by alleged materially misleading statements and/or material omissions by the Company and the individual directors and officers regarding its 32nm technology and “Llano” product, which statements and omissions, the plaintiffs claim, allegedly operated to artificially inflate the price paid for the Company’s common stock during the period. On April 27, 2015, a similar purported shareholder derivative lawsuit captioned Christopher Hamilton and David Hamilton v. Barnes, et al. , Case No. 5:15-cv-01890 (Hamilton) was filed against the Company (as a nominal defendant only) and certain of its directors and officers in the United States District Court for the Northern District of California. On September 29, 2015, a similar purported shareholder derivative lawsuit captioned Jake Ha v Caldwell, et al., Case No. 3:15-cv-04485 (Ha) was filed against the Company (as a nominal defendant only) and certain of its directors and officers in the United States District Court for the Northern District of California. The lawsuit also seeks a court order voiding the stockholder vote on the Company’s 2015 proxy. The case was transferred to the judge handling the Hamilton Lawsuit and is now Case No. 4:15-cv-04485. The Wessels, Hamilton and Ha shareholder derivative lawsuits were stayed pending resolution of a class action lawsuit captioned Hatamian v. AMD, et al. , C.A. No. 3:14-cv-00226 filed against the Company in the United States District Court for the Northern District of California (the Hatamian Lawsuit). The Hatamian Lawsuit asserted claims against the Company and certain of its officers for alleged violations of Section 10(b) of the Securities Exchange Act of 1934, as amended (the Exchange Act), and SEC Rule 10b-5 concerning certain statements regarding our 32nm technology and “Llano” products. On October 9, 2017, the parties signed a definitive settlement agreement resolving the Hatamian Lawsuit and submitted it to the Court for approval. Under the terms of this agreement, the settlement was funded entirely by certain of AMD’s insurance carriers and the defendants continued to deny any liability or wrongdoing. On March 2, 2018, the court approved the settlement and entered a final judgment in the Hatamian lawsuit. On January 30, 2018, the Wessels and Hamilton plaintiffs amended their complaints. On February 2, 2018, the Ha plaintiff also filed an amended complaint. On February 22, 2018, the Company filed motions to dismiss the Hamilton and Ha plaintiffs’ amended complaints. On April 2, 2018, the Company filed a demurrer seeking to dismiss the Wessels amended complaint. On July 23, 2018, the Santa Clara Superior Court sustained the Company's demurrer in the Wessels case, dismissing all claims in that matter with prejudice. The Wessels plaintiff filed a Notice of Appeal on September 27, 2018. On October 4, 2018, the Federal Court issued an order dismissing the Hamilton and Ha amended complaints. The Hamilton plaintiffs filed a Notice of Appeal on October 8, 2018, and the Ha plaintiffs filed a Notice of Appeal on October 15, 2018. On November 19, 2018, the Hamilton and Ha plaintiffs filed a motion seeking summary reversal of the order dismissing their claims. The Company opposed this motion on December 13, 2018, and the Court denied it on February 25, 2019. The Wessels, Hamilton, and Ha appeals are currently pending. Briefing in each appeal is scheduled to be completed later this year. Based upon information presently known to management, the Company believes that the potential liability, if any, will not have a material adverse effect on its financial condition, cash flows or results of operations. Hauck et al. Litigation Since January 19, 2018, three putative class action complaints have been filed against the Company in the United States District Court for the Northern District of California: (1) Diana Hauck et al. v. AMD, Inc., Case No. 5:18-cv-0047, filed on January 19, 2018; (2) Brian Speck et al. v. AMD, Inc. , Case No. 5:18-cv-0744, filed on February 4, 2018; and (3) Nathan Barnes and Jonathan Caskey-Medina, et al. v. AMD, Inc. , Case No. 5:18-cv-00883, filed on February 9, 2018. On April 9, 2018, the court consolidated these cases and ordered that Diana Hauck et al. v. AMD, Inc. serve as the lead case. On June 13, 2018, six plaintiffs (from California, Louisiana, Florida, and Massachusetts) filed a consolidated amended complaint alleging that the Company failed to disclose its processors’ alleged vulnerability to Spectre. Plaintiffs further allege that the Company's processors cannot perform at its advertised processing speeds without exposing consumers to Spectre, and that any “patches” to remedy this security vulnerability will result in degradation of processor performance. The plaintiffs seek damages under several causes of action on behalf of a nationwide class and four state subclasses (California, Florida, Massachusetts, Louisiana) of consumers who purchased AMD processors and/or devices containing AMD processors. The plaintiffs also seek attorneys’ fees, equitable relief, and restitution. Pursuant to the court's order directing parties to litigate only eight of the causes of action in the consolidated amended complaint initially, the Company filed a motion to dismiss on July 13, 2018. On October 29, 2018, after the plaintiffs voluntarily dismissed one of their claims, the court granted the Company's motion and dismissed six causes of action with leave to amend. The plaintiffs filed their amended consolidated complaint on December 6, 2018. On January 3, 2019, the Company again moved to dismiss the subset of claims currently at issue. On April 4, 2019, the court granted the Company's motion and dismissed all claims currently at issue with prejudice. A case management conference is scheduled for May 8, 2019 where the parties and the court will discuss how the case will proceed in light of the court's ruling. Based upon information presently known to management, the Company believes that the potential liability, if any, will not have a material adverse effect on its financial condition, cash flows or results of operations. MediaTek Litigation MediaTek, Inc. v. Advanced Micro Devices, Inc ., No. 19-cv-368 in the United States District Court for the District of Delaware. On February 21, 2019, MediaTek, Inc. filed suit against the Company, alleging infringement of six patents related to memory controllers and integrated circuit structures. On April 15, 2019, the Company filed a motion to dismiss portions of MediaTek's complaint. On April 29, 2019, MediaTek filed an amended complaint. On March 18, 2019, AMD Products (China) Co., Ltd. was provided with four complaints filed by MediaTek in the Intermediate People’s Court of Shenzhen, China. Each complaint alleges infringement of one patent by certain AMD entities, identifies an exemplary product, and seeks injunctive and monetary relief: • MediaTek Inc. v. Advanced Micro Devices, Inc., AMD Products (China) Co., Ltd, and Shenzhen Ningjing Technology Co., Ltd., 2019 Yue 03 Min Chu No. 725 (Intermediate People’s Court of Shenzhen, China). On March 18, 2019, AMD Products (China) Co., Ltd. was provided with a complaint by the Shenzhen Court. MediaTek alleges that defendants infringe patent 201110060964.1, titled “Integrated Circuit Chip.” On April 2, 2019, the Company submitted a challenge to the Court’s jurisdiction, and separately initiated invalidity proceedings in the Patent Reexamination Board of the China National Intellectual Property Administration (CNIPA). The Court has set an initial hearing for June 20, 2019. • MediaTek Inc. v. Advanced Micro Devices, Inc., AMD Products (China) Co., Ltd. , and Shenzhen Ningjing Technology Co., Ltd., 2019 Yue 03 Min Chu No. 726 (Intermediate People’s Court of Shenzhen, China). On March 18, 2019, AMD Products (China) Co., Ltd. was provided with a complaint by the Shenzhen Court. MediaTek alleges that defendants infringe patent 200920178360.5, titled “Integrated Inductor Structure.” On April 2, 2019, the Company submitted a challenge to the Court’s jurisdiction, and separately initiated invalidity proceedings in the CNIPA. The Court has set an initial hearing for June 20, 2019. • MediaTek Inc. v. Advanced Micro Devices, Inc., Advanced Micro Devices (China) Co., Ltd., AMD Products (China) Co., Ltd. and Shenzhen Shundian Chain Co., Ltd., Nanshan Wanxiang Tiandi Branch Store, . 2019 Yue 03 Min Chu No. 727 (Intermediate People’s Court of Shenzhen, China). On March 18, 2019, AMD Products (China) Co., Ltd. was provided with a complaint by the Shenzhen Court. MediaTek alleges that defendants infringe patent 200910000212.9, titled “Integrated Circuit Chip and Seal Ring Structure of the Same.” On April 2, 2019, the Company submitted a challenge to the Court’s jurisdiction, and separately initiated invalidity proceedings in the CNIPA. The Court has set an initial hearing for June 21, 2019. • MediaTek, Inc. v. Advanced Micro Devices, Inc., Advanced Micro Devices (China) Co., Ltd., AMD Products (China) Co., Ltd. and Shenzhen Shundian Chain Co., Ltd. Nanshan Wanxiang Tiandi Branch Store, 2019 Yue 03 Min Chu No. 728 (Intermediate People’s Court of Shenzhen, China). On March 18, 2019, AMD Products (China) Co., Ltd. was provided with a complaint by the Shenzhen Court. MediaTek alleges that defendants infringe patent 200910000930.6, titled “Seal Ring Structure for Integrated Circuit.” On April 2, 2019, the Company submitted a challenge to the Court’s jurisdiction, and separately initiated invalidity proceedings in the CNIPA. The Court has set an initial hearing for June 21, 2019. Based upon information presently known to management, the Company believes that the potential liability, if any, will not have a material adverse effect on its financial condition, cash flows or results of operations. Other Legal Matters The Company is a defendant or plaintiff in various actions that arose in the normal course of business. With respect to these matters, the Company believes that the amount or range of reasonably possible loss, if any, will not, either individually or in the aggregate, have a material adverse effect on the Company’s business, financial condition, cash flows or results of operations . |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income (Loss) | 3 Months Ended |
Mar. 30, 2019 | |
Equity [Abstract] | |
Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss) The tables below summarize the changes in accumulated other comprehensive income (loss) by component: Unrealized gains (losses) on cash flow hedges Three Months Ended March 30, March 31, (In millions) Beginning balance $ (8 ) $ 6 Unrealized gains arising during the period 5 1 (Gains) losses reclassified into income 2 (4 ) Total other comprehensive income (loss) 7 (3 ) Ending balance $ (1 ) $ 3 |
Leases
Leases | 3 Months Ended |
Mar. 30, 2019 | |
Leases [Abstract] | |
Leases | Leases The Company has entered into operating and finance leases for its corporate office, datacenters and research and development facilities and certain equipment. The leases expire at various dates through 2028, some of which include options to extend the lease for up to 5 years , and some of which include options to terminate the lease within 1 year . For the three months ended March 30, 2019, the Company recorded $13 million of operating lease expense. The Company's finance leases and short-term leases are immaterial. Supplemental cash flow information related to leases is as follows: March 30, 2019 (In millions) Cash paid for operating leases included in operating cash flows $ 9 Weighted-average remaining lease term – operating leases 7 years Weighted-average discount rate – operating leases 6.20 % Future minimum lease payments under non-cancellable operating lease liabilities are as follows: March 30, 2019 (In millions) 2019 (9 months remaining) $ 41 2020 49 2021 43 2022 40 2023 36 Thereafter 103 Total minimum lease payments $ 312 Less: interest (61 ) Present value of net minimum lease payments 251 Less: current portion (38 ) Total $ 213 |
Basis of Presentation and Sig_2
Basis of Presentation and Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 30, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation. The accompanying unaudited condensed consolidated financial statements of Advanced Micro Devices, Inc. and its subsidiaries (the Company or AMD) have been prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP) for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. The results of operations for the three months ended March 30, 2019 shown in this report are not necessarily indicative of results to be expected for the full year ending December 28, 2019 . In the opinion of the Company’s management, the information contained herein reflects all adjustments necessary for a fair presentation of the Company’s results of operations, financial position, cash flows and s tockholders' equity . All such adjustments are of a normal, recurring nature. The unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements in the Company’s Annual Report on Form 10-K for the fiscal year ended December 29, 2018. |
Fiscal Period | The Company uses a 52 or 53 week fiscal year ending on the last Saturday in December. The three months ended March 30, 2019 and March 31, 2018 each consisted of 13 weeks. |
Principles of Consolidation | Principles of Consolidation. The condensed consolidated financial statements include the Company’s accounts and those of its wholly-owned subsidiaries. Upon consolidation, all significant inter-company accounts and transactions are eliminated. |
Leases | Leases. The Company determines if an arrangement is a lease, or contains a lease, at the inception of the arrangement. When the Company determines the arrangement is a lease, or contains a lease, at lease inception, it then determines whether the lease is an operating lease or a finance lease at the commencement date. Operating and finance leases result in the Company recording a right-of-use (ROU) asset and lease liability on its balance sheet. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent its obligation to make lease payments arising from the lease. Operating and finance lease ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. In determining the present value of lease payments, the Company uses the implicit interest rate if readily determinable. When the implicit rate is not readily determinable, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The operating lease ROU asset is recognized net of any lease payments made and any lease incentives. Specific lease terms may include options to extend or terminate the lease when the Company believes it is reasonably certain that it will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. As allowed by the guidance, the Company has elected not to recognize ROU assets and lease liabilities that arise from short-term (12 months or less) leases for any class of underlying asset. Operating leases are included in operating lease ROU assets, other current liabilities, and long-term operating lease liabilities in the Company's condensed consolidated balance sheet. The Company's finance leases are immaterial. |
Derivative Financial Instruments | Derivative Financial Instruments. The Company maintains a foreign currency hedging strategy which uses derivative financial instruments to mitigate the risks associated with changes in foreign currency exchange rates. This strategy takes into consideration all of the Company’s consolidated exposures. The Company does not use derivative financial instruments for trading or speculative purposes. In applying its strategy, the Company uses foreign currency forward contracts to hedge certain forecasted expenses denominated in foreign currencies. The Company designates these contracts as cash flow hedges of forecasted expenses, to the extent eligible under the accounting rules, and evaluates hedge effectiveness prospectively and retrospectively. As such, the effective portion of the gain or loss on these contracts is reported as a component of accumulated other comprehensive income (loss) and is reclassified to earnings in the same line item as the associated forecasted transaction and in the same period during which the hedged transaction affects earnings. For periods prior to the three months ended March 30, 2019, any ineffective portion was immediately recorded in Other income (expense), net. As a result of adopting ASU 2017-12, Derivatives and Hedging (ASC 815): Targeted Improvements to Accounting for Hedging Activities (ASU 2017-12) , beginning in January 2019, the ineffective portion will be held in accumulated other comprehensive income (loss) until the associated forecasted transaction affects earnings and such amounts are included in the same line item in earnings as the associated forecasted transaction. The Company also uses, from time to time, foreign currency forward contracts to economically hedge recognized foreign currency exposures on the balance sheets of various subsidiaries. The Company does not designate these forward contracts as hedging instruments. Accordingly, the gain or loss associated with these contracts is immediately recorded in earnings. |
Recently Adopted and Issued Accounting Standards | Recently Adopted Accounting Standards Fair Value Measurement. In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (ASC 820) , which amends disclosure requirements for fair value measurement. ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods therein with early adoption permitted. The Company early adopted this guidance in the first quarter of 2019 with no material impact on its consolidated financial statements. Leases. In February 2016, the FASB issued ASU 2016-02, Leases (ASC 842) , to increase transparency and comparability among organizations for lease recognition and disclosure. ASU 2016-02 requires lessees to recognize lease assets and lease liabilities on the balance sheet, while recognizing expenses on the income statements in a manner similar to legacy guidance. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018. The Company adopted the new standard using the optional adoption method in the first quarter of 2019, whereby the Company did not have to adjust comparative period financial statements for the new standard and recorded $228 million of right-of-use assets and $261 million of lease liabilities primarily related to office buildings in its consolidated balance sheet as of December 30, 2018. The Company's accounting for capital leases, now referred to as finance leases, remains substantially unchanged. The Company's adoption of the new standard had no impact on its consolidated statement of operations or on net cash provided by or used in operating, financing, or investing activities on its consolidated statement of cash flows. Upon adoption, the Company elected a transition practical expedient under the new accounting standard allowing it not to separate lease and non-lease components and instead to account for each separate lease component and non-lease component as a single lease component. The Company implemented internal controls and key system functionality to enable the preparation of financial information on adoption. Reporting Comprehensive Income . In February 2018, the FASB issued ASU 2018-02, Income Statement — Reporting Comprehensive Income (ASC 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (AOCI) , which allows companies to reclassify certain tax effects resulting from the 2017 Tax Cuts and Jobs Act (Tax Act), from accumulated other comprehensive income to retained earnings. ASU 2018-02 is effective for fiscal years beginning after December 15, 2018. The Company adopted this guidance in the first quarter of 2019 with no impact on its consolidated financial statements. Derivatives and Hedging. In August 2017, the FASB issued ASU 2017-12, which amends and simplifies existing guidance to allow companies to more accurately present the economic effects of risk management activities in the financial statements. ASU 2017-12 is effective for fiscal years beginning after December 15, 2018. The Company adopted this guidance in the first quarter of 2019 with no material impact on its consolidated financial statements. Recently Issued Accounting Standards There were no other significant updates to the recently issued accounting standards other than as disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 29, 2018. Although there are several other new accounting pronouncements issued or proposed by the FASB, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its consolidated financial position or operating results. |
Supplemental Balance Sheet In_2
Supplemental Balance Sheet Information (Tables) | 3 Months Ended |
Mar. 30, 2019 | |
Balance Sheet Related Disclosures [Abstract] | |
Inventories, Net | Inventories, net March 30, December 29, (In millions) Raw materials $ 120 $ 134 Work in process 548 354 Finished goods 287 357 Total inventories, net $ 955 $ 845 |
Property and Equipment, Net | Property and Equipment, net March 30, December 29, (In millions) Leasehold improvements $ 181 $ 179 Equipment 808 798 Construction in progress 112 78 Property and equipment, gross 1,101 1,055 Accumulated depreciation (724 ) (707 ) Total property and equipment, net $ 377 $ 348 |
Other Assets | Other Assets March 30, December 29, (In millions) Software technology and licenses, net $ 222 $ 226 Other 95 95 Total other assets $ 317 $ 321 |
Accrued Liabilities | Accrued Liabilities March 30, December 29, (In millions) Accrued compensation and benefits $ 226 $ 236 Marketing programs and advertising expenses 241 275 Software technology and licenses payable 56 28 Other 196 224 Total accrued liabilities $ 719 $ 763 |
Other Current Liabilities | Other Current Liabilities March 30, December 29, (In millions) Unearned revenue $ 2 $ 11 Operating lease liabilities 38 — Other 5 13 Total other current liabilities $ 45 $ 24 |
Changes in Unearned Revenue | Changes in unearned revenue were as follows: Three Months Ended March 30, March 31, (In millions) Beginning balance $ 11 $ 85 Unearned revenue 1 86 Revenue recognized during the period (10 ) (24 ) Ending balance $ 2 $ 147 |
Debt and Secured Revolving Li_2
Debt and Secured Revolving Line of Credit (Tables) | 3 Months Ended |
Mar. 30, 2019 | |
Debt Disclosure [Abstract] | |
Convertible Debt | The 2.125% Notes consisted of the following: March 30, December 29, (In millions) Principal amounts: Principal $ 805 $ 805 Unamortized debt discount (1) (256 ) (262 ) Unamortized debt issuance costs (10 ) (11 ) Net carrying amount $ 539 $ 532 Carrying amount of the equity component, net (2) $ 305 $ 305 (1) Included in the consolidated balance sheets within Long-term debt, net and amortized over the remaining life of the notes using the effective interest rate method. (2) Included in the consolidated balance sheets within additional paid-in capital, net of $9 million of equity issuance cost . The following table sets forth total interest expense recognized related to the 2.125% Notes: |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 3 Months Ended |
Mar. 30, 2019 | |
Earnings Per Share [Abstract] | |
Components of Basic and Diluted Earnings (Loss) Per Share | The following table sets forth the components of basic and diluted earnings per share: Three Months Ended March 30, March 31, (In millions, except per share amounts) Numerator Net income $ 16 $ 81 Denominator Basic weighted-average shares 1,044 968 Effect of potentially dilutive shares: Employee equity incentive plans and warrants 50 71 Diluted weighted-average shares 1,094 1,039 Earnings per share: Basic $ 0.01 $ 0.08 Diluted $ 0.01 $ 0.08 |
Financial Instruments (Tables)
Financial Instruments (Tables) | 3 Months Ended |
Mar. 30, 2019 | |
Investments, Debt and Equity Securities [Abstract] | |
Cash, Cash Equivalents, and Marketable Securities | Cash and financial instruments measured and recorded at fair value as of March 30, 2019 and December 29, 2018 are summarized below: Total Fair Cash and Short-Term Marketable Securities (In millions) March 30, 2019 Cash $ 630 $ 630 $ — Level 1 (1) Government money market funds $ 5 $ 5 $ — Total level 1 $ 5 $ 5 $ — Level 2 (2) Commercial paper $ 559 $ 343 $ 216 Total level 2 $ 559 $ 343 $ 216 Total $ 1,194 $ 978 $ 216 Total Fair Cash and Short-Term Marketable Securities (In millions) December 29, 2018 Cash $ 315 $ 315 $ — Level 1 (1) Government money market funds $ 275 $ 275 $ — Total level 1 $ 275 $ 275 $ — Level 2 (2) Commercial paper $ 566 $ 488 $ 78 Total level 2 $ 566 $ 488 $ 78 Total $ 1,156 $ 1,078 $ 78 (1) The Company ’ s Level 1 assets are valued using quoted prices for identical instruments in active markets. (2) The Company’s Level 2 assets are valued using broker reports that utilize quoted prices for identical instruments in markets that are not active or comparable instruments in active markets. Brokers gather observable inputs for all of the Company’s fixed income securities from a variety of industry data providers and other third-party sources. |
Financial Instruments Not Recorded at Fair Value on a Recurring Basis | The carrying amounts and estimated fair values of financial instruments not recorded at fair value are as follows: March 30, 2019 December 29, 2018 Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value (In millions) Short-term debt, net $ 70 $ 70 $ 136 $ 136 Long-term debt, net (1) $ 1,024 $ 3,147 $ 1,114 $ 2,428 (1) Carrying amounts of long-term debt are net of unamortized debt issuance costs of $14 million as of March 30, 2019 and $16 million as of December 29, 2018 , and net of unamortized debt discount associated with the 2.125% Notes of $256 million as of March 30, 2019 and $262 million as of December 29, 2018 . |
Schedule of Derivative Instruments, Gains (Losses) in Statement of Operations | Gains (Losses) Recognized in Income Three Months Ended March 30, March 31, Research and development Marketing, general and administrative Other income (expense), net Research and development Marketing, general and administrative Other income (expense), net (In millions) Total amounts presented in the condensed consolidated statements of operations in which the effects of cash flow hedges were recorded $ 373 $ 170 $ (7 ) $ 343 $ 134 $ 1 Foreign Currency Forward Contracts - gains (losses) Contracts designated as cash flow hedging instruments Gains (losses) reclassified from OCI into income (2 ) — — 3 1 — Contracts not designated as hedging instruments Gains (losses) recognized in income — — — — — (2 ) Total Gains (losses) $ (2 ) $ — $ — $ 3 $ 1 $ (2 ) |
Schedule of Fair Value Amounts of Foreign Currency Forward Contracts in Balance Sheet | The following table shows the fair value amounts included in Other current assets should the foreign currency forward contracts be in a gain position or included in Other current liabilities should these contracts be in a loss position. These amounts were recorded in the Company’s condensed consolidated balance sheets as follows: March 30, December 29, (In millions) Foreign Currency Forward Contracts - gains (losses) Contracts designated as cash flow hedging instruments - Gain $ 3 $ 8 Contracts designated as cash flow hedging instruments - Loss $ (3 ) $ (1 ) |
Segment Reporting (Tables)
Segment Reporting (Tables) | 3 Months Ended |
Mar. 30, 2019 | |
Segment Reporting [Abstract] | |
Summary of Net Revenue and Operating Income (Loss) by Segment | The following table provides a summary of net revenue and operating income by segment: Three Months Ended March 30, March 31, (In millions) Net revenue: Computing and Graphics $ 831 $ 1,115 Enterprise, Embedded and Semi-Custom 441 532 Total net revenue $ 1,272 $ 1,647 Operating income (loss): Computing and Graphics $ 16 $ 138 Enterprise, Embedded and Semi-Custom 68 14 All Other (1) (46 ) (32 ) Total operating income $ 38 $ 120 (1) All Other operating losses consisted of $41 million of stock-based compensation expense and a $5 million contingent loss in connection with a legal matter for the three months ended March 30, 2019 and $32 million stock-based compensation expense for the three months ended March 31, 2018 . |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income (Loss) (Tables) | 3 Months Ended |
Mar. 30, 2019 | |
Equity [Abstract] | |
Schedule of Accumulated Other Comprehensive Income (Loss) | The tables below summarize the changes in accumulated other comprehensive income (loss) by component: Unrealized gains (losses) on cash flow hedges Three Months Ended March 30, March 31, (In millions) Beginning balance $ (8 ) $ 6 Unrealized gains arising during the period 5 1 (Gains) losses reclassified into income 2 (4 ) Total other comprehensive income (loss) 7 (3 ) Ending balance $ (1 ) $ 3 |
Leases (Tables)
Leases (Tables) | 3 Months Ended |
Mar. 30, 2019 | |
Leases [Abstract] | |
Schedule of Leases, Supplemental Cash Flows | Supplemental cash flow information related to leases is as follows: March 30, 2019 (In millions) Cash paid for operating leases included in operating cash flows $ 9 Weighted-average remaining lease term – operating leases 7 years Weighted-average discount rate – operating leases 6.20 % |
Operating Lease, Liability, Maturity | Future minimum lease payments under non-cancellable operating lease liabilities are as follows: March 30, 2019 (In millions) 2019 (9 months remaining) $ 41 2020 49 2021 43 2022 40 2023 36 Thereafter 103 Total minimum lease payments $ 312 Less: interest (61 ) Present value of net minimum lease payments 251 Less: current portion (38 ) Total $ 213 |
Basis of Presentation and Sig_3
Basis of Presentation and Significant Accounting Policies (Details) - USD ($) $ in Millions | Mar. 30, 2019 | Dec. 30, 2018 | Dec. 29, 2018 |
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Operating lease right-of-use assets | $ 214 | $ 0 | |
Operating lease liabilities | $ 251 | ||
Accounting Standards Update 2016-02 | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Operating lease right-of-use assets | $ 228 | ||
Operating lease liabilities | $ 261 |
GLOBALFOUNDRIES (Details)
GLOBALFOUNDRIES (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |||
Mar. 30, 2019 | Mar. 31, 2018 | Dec. 29, 2018 | Aug. 30, 2016 | |
Related Party Transaction [Line Items] | ||||
Prepayment and receivables—related parties | $ 50 | $ 52 | ||
Payables to related parties | 446 | 533 | ||
Proceeds from warrant exercise by related party | $ 449 | $ 0 | ||
Related Party | WCH | WCH Warrant | ||||
Related Party Transaction [Line Items] | ||||
Number of securities called by warrants (in shares) | 75,000,000 | |||
Exercise price of warrants (in usd per share) | $ 5.98 | $ 5.98 | ||
Warrants exercised (in shares) | 75,000,000 | |||
Proceeds from warrant exercise by related party | $ 448.5 | |||
Related Party | GF | ||||
Related Party Transaction [Line Items] | ||||
Purchases from related party | 378 | $ 398 | ||
Prepayment and receivables—related parties | 12 | 18 | ||
Payables to related parties | $ 246 | $ 326 |
Supplemental Balance Sheet In_3
Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 30, 2019 | Mar. 31, 2018 | Dec. 29, 2018 | |
Accounts Receivable, Net | |||
Unbilled accounts receivables | $ 353 | $ 308 | |
Inventories, Net | |||
Raw materials | 120 | 134 | |
Work in process | 548 | 354 | |
Finished goods | 287 | 357 | |
Total inventories, net | 955 | 845 | |
Property and Equipment, Net | |||
Leasehold improvements | 181 | 179 | |
Equipment | 808 | 798 | |
Construction in progress | 112 | 78 | |
Property and equipment, gross | 1,101 | 1,055 | |
Accumulated depreciation | (724) | (707) | |
Total property and equipment, net | 377 | 348 | |
Other Assets | |||
Software technology and licenses, net | 222 | 226 | |
Other | 95 | 95 | |
Total other assets | 317 | 321 | |
Accrued Liabilities | |||
Accrued compensation and benefits | 226 | 236 | |
Marketing programs and advertising expenses | 241 | 275 | |
Software technology and licenses payable | 56 | 28 | |
Other | 196 | 224 | |
Total accrued liabilities | 719 | 763 | |
Other Current Liabilities | |||
Unearned revenue | 2 | 11 | |
Operating lease liabilities | 38 | 0 | |
Other | 5 | 13 | |
Total other current liabilities | 45 | $ 24 | |
Changes in Unearned Revenue | |||
Beginning balance | 11 | $ 85 | |
Unearned revenue | 1 | 86 | |
Revenue recognized during the period | (10) | (24) | |
Ending balance | $ 2 | $ 147 |
Supplemental Balance Sheet In_4
Supplemental Balance Sheet Information (Remaining Performance Obligations) (Details) $ in Millions | Mar. 30, 2019USD ($) |
Balance Sheet Related Disclosures [Abstract] | |
Revenue allocated to remaining performance obligations that are unsatisfied or partially unsatisfied | $ 70 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-03-31 | |
Balance Sheet Related Disclosures [Abstract] | |
Revenue allocated to remaining performance obligations that are unsatisfied or partially unsatisfied | $ 70 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Performance obligations expected to be satisfied, expected timing | 1 year |
Equity Interest Purchase Agre_2
Equity Interest Purchase Agreement - ATMP Joint Venture (Details) $ in Millions | 3 Months Ended | ||
Mar. 30, 2019USD ($)joint_venture | Mar. 31, 2018USD ($) | Dec. 29, 2018USD ($) | |
Investment [Line Items] | |||
Carrying value of investment | $ 57 | $ 58 | |
Payables to related parties | 446 | 533 | |
Receivables from related parties | 50 | 52 | |
Equity loss in investee | $ 1 | $ 1 | |
ATMP JV | |||
Investment [Line Items] | |||
Number of joint ventures | joint_venture | 2 | ||
Carrying value of investment | $ 57 | 58 | |
ATMP JV | Joint Venture | |||
Investment [Line Items] | |||
Ownership percentage | 15.00% | ||
Purchases from related party | $ 132 | 135 | |
Payables to related parties | 201 | 207 | |
Revenue from related parties | 26 | 6 | |
Receivables from related parties | 25 | $ 16 | |
Equity loss in investee | $ 1 | $ 1 |
Equity Joint Venture (Details)
Equity Joint Venture (Details) $ in Millions | 3 Months Ended | |||
Mar. 30, 2019USD ($) | Mar. 31, 2018USD ($) | Dec. 29, 2018USD ($) | Feb. 29, 2016USD ($)legal_entity | |
Schedule of Equity Method Investments [Line Items] | ||||
Operating income | $ 60 | $ 0 | ||
Carrying value of investment | 57 | $ 58 | ||
Prepayment and receivables—related parties | 50 | 52 | ||
THATIC JV | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Number of legal entities | legal_entity | 2 | |||
Prepayment and receivables—related parties | 13 | $ 18 | ||
THATIC JV | Licensing gain | ||||
Schedule of Equity Method Investments [Line Items] | ||||
Estimated license fees expected to be earned over several years pursuant to a licensing agreement | $ 293 | |||
Operating income | $ 60 |
Debt and Secured Revolving Li_3
Debt and Secured Revolving Line of Credit (Narrative) (Details) | 1 Months Ended | 3 Months Ended | ||||||
Sep. 30, 2016USD ($)day | Mar. 30, 2019USD ($)$ / shares | Mar. 31, 2018USD ($) | Mar. 29, 2019$ / shares | Dec. 29, 2018USD ($) | Jun. 16, 2014USD ($) | Feb. 26, 2014USD ($) | Aug. 15, 2012USD ($) | |
Debt Instrument [Line Items] | ||||||||
Aggregate principal amount repurchased | $ 164,000,000 | $ 14,000,000 | ||||||
Loss on debt redemption | 8,000,000 | $ 1,000,000 | ||||||
Secured Revolving Line of Credit | ||||||||
Debt Instrument [Line Items] | ||||||||
Secured revolving line of credit, outstanding balance | $ 70,000,000 | $ 70,000,000 | ||||||
Secured revolving line of credit, interest rate | 6.00% | 6.00% | ||||||
Letters of credit outstanding, amount | $ 26,000,000 | |||||||
Secured revolving line of credit, remaining borrowing capacity (up to) | $ 119,000,000 | |||||||
Repayment period | 90 days | |||||||
Secured Revolving Line of Credit | Amended and restated loan and security agreement | ||||||||
Debt Instrument [Line Items] | ||||||||
Maximum borrowing capacity | $ 500,000,000 | |||||||
Maximum letters of credit available for issuance | 45,000,000 | |||||||
Aggregate amount by which size of commitments may be increased (up to) | $ 200,000,000 | |||||||
Secured Revolving Line of Credit | Amended and restated loan and security agreement | Federal Funds Rate | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable rate | 0.50% | |||||||
Secured Revolving Line of Credit | Amended and restated loan and security agreement | LIBOR | ||||||||
Debt Instrument [Line Items] | ||||||||
Basis spread on variable rate | 1.00% | |||||||
2.125% Convertible Senior Notes due 2026 | ||||||||
Debt Instrument [Line Items] | ||||||||
Stated interest rate | 2.125% | |||||||
Principal amount | $ 805,000,000 | $ 805,000,000 | $ 805,000,000 | |||||
Outstanding aggregate principal amount | $ 805,000,000 | |||||||
Conversion price (in dollars per share) | $ / shares | $ 8 | |||||||
Remaining life | 90 months | |||||||
Share price (in usd per share) | $ / shares | $ 25.52 | |||||||
If-converted value in excess of principal | $ 1,763,000,000 | |||||||
Effective interest rate | 8.00% | |||||||
2.125% Convertible Senior Notes due 2026 | Debt Instrument, circumstance 1 | ||||||||
Debt Instrument [Line Items] | ||||||||
Threshold trading days | day | 20 | |||||||
Threshold consecutive trading days | day | 30 | |||||||
Threshold percentage of conversion price | 130.00% | |||||||
2.125% Convertible Senior Notes due 2026 | Debt Instrument, circumstance 2 | ||||||||
Debt Instrument [Line Items] | ||||||||
Threshold consecutive trading days | day | 10 | |||||||
Threshold percentage of conversion price | 98.00% | |||||||
Conversion period after threshold period days | day | 5 | |||||||
6.75% Senior Notes due 2019 | ||||||||
Debt Instrument [Line Items] | ||||||||
Stated interest rate | 6.75% | |||||||
Principal amount | $ 600,000,000 | |||||||
Aggregate principal amount repurchased | $ 66,000,000 | |||||||
7.50% Senior Notes due 2022 | ||||||||
Debt Instrument [Line Items] | ||||||||
Stated interest rate | 7.50% | |||||||
Principal amount | $ 500,000,000 | |||||||
Outstanding aggregate principal amount | 312,000,000 | |||||||
Aggregate principal amount settled | 25,000,000 | |||||||
7.00% Senior Notes due 2024 | ||||||||
Debt Instrument [Line Items] | ||||||||
Stated interest rate | 7.00% | |||||||
Principal amount | $ 500,000,000 | |||||||
Outstanding aggregate principal amount | 176,000,000 | |||||||
Aggregate principal amount repurchased | $ 74,000,000 |
Debt and Secured Revolving Li_4
Debt and Secured Revolving Line of Credit (Convertible Debt) (Details) - 2.125% Convertible Senior Notes due 2026 - USD ($) | Mar. 30, 2019 | Dec. 29, 2018 | Sep. 30, 2016 |
Debt Instrument [Line Items] | |||
Principal | $ 805,000,000 | $ 805,000,000 | $ 805,000,000 |
Unamortized debt discount | (256,000,000) | (262,000,000) | |
Unamortized debt issuance costs | (10,000,000) | (11,000,000) | |
Net carrying amount | 539,000,000 | 532,000,000 | |
Carrying amount of the equity component, net | 305,000,000 | 305,000,000 | |
Equity issuance costs | $ 9,000,000 | $ 9,000,000 |
Debt and Secured Revolving Li_5
Debt and Secured Revolving Line of Credit (Interest Expense Recognized) (Details) - 2.125% Convertible Senior Notes due 2026 - USD ($) $ in Millions | 3 Months Ended | |
Mar. 30, 2019 | Mar. 31, 2018 | |
Debt Instrument [Line Items] | ||
Contractual interest expense | $ 4 | $ 4 |
Interest cost related to amortization of the debt discount | $ 6 | $ 6 |
Earnings Per Share (Details)
Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | |
Mar. 30, 2019 | Mar. 31, 2018 | |
Numerator | ||
Net income | $ 16 | $ 81 |
Denominator | ||
Basic weighted-average shares (in shares) | 1,044 | 968 |
Effect of potentially dilutive shares: | ||
Employee equity incentive plans and warrants (in shares) | 50 | 71 |
Diluted weighted-average shares (in shares) | 1,094 | 1,039 |
Earnings per share: | ||
Basic (in usd per share) | $ 0.01 | $ 0.08 |
Diluted (in usd per share) | $ 0.01 | $ 0.08 |
Earnings Per Share (Narrative)
Earnings Per Share (Narrative) (Details) - shares shares in Millions | 3 Months Ended | |
Mar. 30, 2019 | Mar. 31, 2018 | |
Stock Options, Restricted Stock Units, Conversion of Notes, and Warrants Under Warrant Agreement | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive shares (in shares) | 103 | 103 |
2.125% Convertible Senior Notes due 2026 | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Stated interest rate | 2.125% |
Financial Instruments (Cash, Ca
Financial Instruments (Cash, Cash Equivalents, and Marketable Securities Fair Value Measurements) (Details) - USD ($) $ in Millions | Mar. 30, 2019 | Dec. 29, 2018 |
Schedule of Investments [Line Items] | ||
Total Fair Value | $ 1,194 | $ 1,156 |
Cash and Cash Equivalents | 978 | 1,078 |
Short-Term Marketable Securities | 216 | 78 |
Level 1 | ||
Schedule of Investments [Line Items] | ||
Total Fair Value | 5 | 275 |
Cash and Cash Equivalents | 5 | 275 |
Short-Term Marketable Securities | 0 | 0 |
Level 2 | ||
Schedule of Investments [Line Items] | ||
Total Fair Value | 559 | 566 |
Cash and Cash Equivalents | 343 | 488 |
Short-Term Marketable Securities | 216 | 78 |
Cash | ||
Schedule of Investments [Line Items] | ||
Total Fair Value | 630 | 315 |
Cash and Cash Equivalents | 630 | 315 |
Short-Term Marketable Securities | 0 | 0 |
Government money market funds | Level 1 | ||
Schedule of Investments [Line Items] | ||
Total Fair Value | 5 | 275 |
Cash and Cash Equivalents | 5 | 275 |
Short-Term Marketable Securities | 0 | 0 |
Commercial paper | Level 2 | ||
Schedule of Investments [Line Items] | ||
Total Fair Value | 559 | 566 |
Cash and Cash Equivalents | 343 | 488 |
Short-Term Marketable Securities | $ 216 | $ 78 |
Financial Instruments (Narrativ
Financial Instruments (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |
Mar. 30, 2019 | Dec. 29, 2018 | |
Foreign Currency Forward Contracts | ||
Schedule of Investments [Line Items] | ||
Contract maturity period | 12 months | |
Maximum length of time hedged in foreign currency cash flow hedges | 12 months | |
Cash Flow Hedging | Foreign Currency Forward Contracts | ||
Schedule of Investments [Line Items] | ||
Derivative, notional amount | $ 517 | $ 396 |
Level 1 | Government money market funds | ||
Schedule of Investments [Line Items] | ||
Investment in money market fund and bank guarantee | 5 | 5 |
Level 1 | Mutual funds | ||
Schedule of Investments [Line Items] | ||
Restricted investments | $ 22 | $ 21 |
2.125% Convertible Senior Notes due 2026 | ||
Schedule of Investments [Line Items] | ||
Stated interest rate | 2.125% | |
Conversion price (in dollars per share) | $ 8 |
Financial Instruments (Schedule
Financial Instruments (Schedule of Carrying Amounts and Estimated Fair Values of Financial Instruments not Recorded at Fair Value) (Details) - USD ($) $ in Millions | Mar. 30, 2019 | Dec. 29, 2018 |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Unamortized debt issuance costs | $ 14 | $ 16 |
2.125% Convertible Senior Notes due 2026 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Stated interest rate | 2.125% | |
Unamortized debt discount | $ 256 | 262 |
Carrying Amount | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term debt, net | 70 | 136 |
Long-term debt, net | 1,024 | 1,114 |
Estimated Fair Value | Level 2 | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Short-term debt, net | 70 | 136 |
Long-term debt, net | $ 3,147 | $ 2,428 |
Financial Instruments (Gain (Lo
Financial Instruments (Gain (Loss) from Hedging Transactions) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 30, 2019 | Mar. 31, 2018 | |
Foreign Currency Forward Contracts - gains (losses) | ||
Research and development | $ 373 | $ 343 |
Marketing, general and administrative | 170 | 134 |
Other income (expense), net | (7) | 1 |
Gains (losses) reclassified from OCI into income | (2) | |
Gains (losses) reclassified from OCI into income | 4 | |
Research and development | ||
Foreign Currency Forward Contracts - gains (losses) | ||
Total Gains (losses) | (2) | 3 |
Marketing, general and administrative | ||
Foreign Currency Forward Contracts - gains (losses) | ||
Total Gains (losses) | 0 | 1 |
Other income (expense), net | ||
Foreign Currency Forward Contracts - gains (losses) | ||
Total Gains (losses) | 0 | (2) |
Foreign Currency Forward Contracts | Contracts designated as hedging instruments | Cash Flow Hedging | Research and development | ||
Foreign Currency Forward Contracts - gains (losses) | ||
Gains (losses) reclassified from OCI into income | (2) | |
Gains (losses) reclassified from OCI into income | 3 | |
Foreign Currency Forward Contracts | Contracts designated as hedging instruments | Cash Flow Hedging | Marketing, general and administrative | ||
Foreign Currency Forward Contracts - gains (losses) | ||
Gains (losses) reclassified from OCI into income | 0 | |
Gains (losses) reclassified from OCI into income | 1 | |
Foreign Currency Forward Contracts | Contracts designated as hedging instruments | Cash Flow Hedging | Other income (expense), net | ||
Foreign Currency Forward Contracts - gains (losses) | ||
Gains (losses) reclassified from OCI into income | 0 | |
Gains (losses) reclassified from OCI into income | 0 | |
Foreign Currency Forward Contracts | Contracts not designated as hedging instruments | Research and development | ||
Foreign Currency Forward Contracts - gains (losses) | ||
Gains (losses) recognized in income | 0 | |
Foreign Currency Forward Contracts | Contracts not designated as hedging instruments | Marketing, general and administrative | ||
Foreign Currency Forward Contracts - gains (losses) | ||
Gains (losses) recognized in income | 0 | 0 |
Foreign Currency Forward Contracts | Contracts not designated as hedging instruments | Other income (expense), net | ||
Foreign Currency Forward Contracts - gains (losses) | ||
Gains (losses) recognized in income | $ 0 | $ (2) |
Financial Instruments (Summary
Financial Instruments (Summary of Derivative Instruments) (Details) - Level 2 - Cash Flow Hedging - Foreign Currency Forward Contracts - USD ($) $ in Millions | Mar. 30, 2019 | Dec. 29, 2018 |
Foreign Currency Forward Contracts - gains (losses) | ||
Gain On Foreign Currency Fair Value Hedge Derivatives | $ 3 | $ 8 |
Loss On Foreign Currency Fair Value Hedge Derivatives | $ (3) | $ (1) |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 30, 2019 | Mar. 31, 2018 | |
Income Tax Disclosure [Abstract] | ||
Provision (benefit) for income taxes | $ (13) | $ 8 |
U.S. based tax expense | 5 | |
Foreign taxes in profitable locations | $ 3 | |
Gross unrecognized tax benefits | $ 50 |
Segment Reporting (Details)
Segment Reporting (Details) $ in Millions | 3 Months Ended | |
Mar. 30, 2019USD ($)segment | Mar. 31, 2018USD ($) | |
Segment Reporting [Abstract] | ||
Number of reportable segments | segment | 2 | |
Segment Reporting Information [Line Items] | ||
Total net revenue | $ 1,272 | $ 1,647 |
Total operating income | 38 | 120 |
Share-based compensation expense | 41 | 32 |
Loss contingency | 5 | |
Operating Segments | Computing and Graphics | ||
Segment Reporting Information [Line Items] | ||
Total net revenue | 831 | 1,115 |
Total operating income | 16 | 138 |
Operating Segments | Enterprise, Embedded and Semi-Custom | ||
Segment Reporting Information [Line Items] | ||
Total net revenue | 441 | 532 |
Total operating income | 68 | 14 |
All Other | ||
Segment Reporting Information [Line Items] | ||
Total operating income | $ (46) | $ (32) |
Stock-Based Incentive Compens_2
Stock-Based Incentive Compensation Plans (Narrative) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | |
Mar. 30, 2019 | Mar. 31, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based compensation expense | $ 41 | $ 32 |
Restricted Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Restricted stock units, shares granted (in shares) | 0.8 | 2.2 |
Restricted stock units, shares granted, weighted average grant date fair value (in usd per share) | $ 24.32 | $ 12.17 |
Contingencies (Details)
Contingencies (Details) | Mar. 18, 2019claimpatent | Feb. 21, 2019patent | Oct. 29, 2018claimcause_of_action | Jun. 13, 2018plaintiff | Mar. 30, 2019claimstate |
Hauck et al. Litigation | |||||
Loss Contingencies [Line Items] | |||||
Number of putative class action complaints filed | 3 | ||||
Number of plaintiffs | plaintiff | 6 | ||||
Number of state in which the plaintiff seeks damages | state | 4 | ||||
Cause of action to be litigated, number | cause_of_action | 8 | ||||
Claims dismissed | 1 | ||||
Causes of action dismissed | cause_of_action | 6 | ||||
MediaTek Litigation | |||||
Loss Contingencies [Line Items] | |||||
Number of putative class action complaints filed | 4 | ||||
Patents allegedly infringed, number | patent | 1 | 6 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 30, 2019 | Mar. 31, 2018 | |
Changes in Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | $ 1,266 | |
Unrealized gains arising during the period | 5 | |
Unrealized gains arising during the period | $ 1 | |
Reclassification adjustment for (gains) losses realized and included in net income | 2 | |
Reclassification adjustment for (gains) losses realized and included in net income | (4) | |
Total other comprehensive income (loss) | 7 | (3) |
Ending balance | 1,788 | 715 |
Accumulated other comprehensive income (loss) | ||
Changes in Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||
Beginning balance | (8) | 6 |
Total other comprehensive income (loss) | 7 | (3) |
Ending balance | $ (1) | $ 3 |
Leases (Narrative) (Details)
Leases (Narrative) (Details) $ in Millions | 3 Months Ended |
Mar. 30, 2019USD ($) | |
Leases [Abstract] | |
Option to extend, term | 5 years |
Option to terminate, term | 1 year |
Operating lease, expense | $ 13 |
Leases (Supplemental Cash Flow
Leases (Supplemental Cash Flow Information) (Details) $ in Millions | 3 Months Ended |
Mar. 30, 2019USD ($) | |
Leases [Abstract] | |
Cash paid for operating leases included in operating cash flows | $ 9 |
Weighted-average remaining lease term – operating leases | 7 years |
Weighted-average discount rate – operating leases | 6.20% |
Leases (Future Minimum Lease Pa
Leases (Future Minimum Lease Payments) (Details) - USD ($) $ in Millions | Mar. 30, 2019 | Dec. 29, 2018 |
Leases [Abstract] | ||
2019 (9 months remaining) | $ 41 | |
2020 | 49 | |
2021 | 43 | |
2022 | 40 | |
2023 | 36 | |
Thereafter | 103 | |
Total minimum lease payments | 312 | |
Less: interest | (61) | |
Present value of net minimum lease payments | 251 | |
Less: current portion | (38) | $ 0 |
Total | $ 213 | $ 0 |